BACKGROUND: This cross-sectional study investigated the relationship between genetic variations in monocarboxylate transporter genes and blood lactate production and removal after high-intensity efforts in humans. The study was conducted to explore how genetic variations in the MCT1, MCT2, and MCT4 genes influenced lactate dynamics and to advance the field of sports genetics by pinpointing critical genetic markers that can enhance athletic performance and recovery. METHODS: 337 male athletes from Poland and the Czech Republic underwent two intermittent all-out Wingate tests. Before the tests, DNA samples were taken from each participant, and SNP (single nucleotide polymorphism) analysis was carried out. Two intermittent all-out tests were implemented, and lactate concentrations were assessed before and after these tests. RESULTS: Sprinters more frequently exhibited the haplotype TAC in the MCT2 gene, which was associated with an increase in the difference between maximum lactate and final lactate concentration. Additionally, this haplotype was linked to higher maximum lactate concentration and was more frequently observed in sprinters. The genotypic interactions AG/T- and GGxT- (MCT1 rs3789592 x MCT4 rs11323780), TTxTT (MCT1 rs12028967 x MCT2 rs3763979), and MCT1 rs7556664 x MCT4 rs11323780 were all associated with an increase in the difference between maximum lactate concentration and final lactate concentration. Conversely, the AGxGG (MCT1 rs3789592 x MCT2 rs995343) interaction was linked to a decrease in this difference. The relationship between maximum lactate concentration and genotypic interactions can be observed as follows: when ATxTT (MCT2 rs3763980 x MCT4 rs11323780) or CTxCT (MCT1 rs10857983 x MCT2 rs3763979) genotypic combinations are present, it leads to a decrease in maximum lactate concentration. Similarly, the combination of CTxCT (MCT1 rs4301628 x MCT2 rs3763979), CT x TT (MCT1 rs4301628 x MCT4 rs11323780), and CTxTT (MCT1 rs4301628 x MCT2 rs3763979) results in decreased maximum lactate concentration. CONCLUSIONS: The TAC haplotype (rs3763980, rs995343, rs3763979) in the MCT2 gene is associated with altered lactate clearance in sprinters, potentially affecting performance and recovery by elevating post-exercise lactate concentrations. While MCT4 rs11323780 is also identified as a significant variant in lactate metabolism, suggesting its role as a biomarker for sprinting performance, further investigation is necessary to clarify underlying mechanisms and consider additional factors. Based on elite male athletes from Poland and the Czech Republic, the study may not generalize to all sprinters or diverse athletic populations. Although genetic variants show promise as biomarkers for sprinting success, athletic performance is influenced by a complex interplay of genetics, environment, and training extending beyond MCT genes.

Department of Laboratory Diagnostics Military Institute of Aviation Medicine Warsaw 01 755 Poland

Faculty of Physical Education and Sport Charles University Prague 162 52 Czech Republic

Faculty of Physical Education Gdansk University of Physical Education and Sport Gdansk 80 336 Poland

Faculty of Physical Education Jozef Pilsudski University of Physical Education in Warsaw Warsaw 00 809 Poland

Warsaw University of Life Sciences SGGW Warsaw 02 787 Poland

Zobrazit více v PubMed

Jones RS, Morris ME. Monocarboxylate transporters: therapeutic targets and prognostic factors in Disease. Clin Pharmacol Ther. 2016;100(5):454–63. PubMed PMC

Jones R, Morris M. Monocarboxylate transporters: therapeutic targets and Prognostic. Clin Pharmacol Ther. 2016;100(5):454–63. PubMed PMC

Halestrap AP. The SLC16 gene family-Structure, role and regulation in health and disease. Mol Asp Med. 2013;34(2–3):337–49. PubMed

Lin RY, Vera JC, Chaganti RSK, Golde DW. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem. 1998;273(44):28959–65. PubMed

Juel C, Halestrap AP. Lactate transport in skeletal muscle - role and regulation of the monocarboxylate transporter. J Physiol. 1999;517(Pt 3):633–42. PubMed PMC

Halestrap AP, Meredith D. The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 2004;447(5):619–28. PubMed

Halestrap AP. The monocarboxylate transporter family-structure and functional characterization. IUBMB Life. 2012;64(1):1–9. PubMed

Turgay F, Bilgin Z, Yigitturk O, Durmaz B, Asikovali S, Koksala A. Does MCT1-T1470A polymorphism modify Lactate kinetics and Training Status? Prog Nutr. 2021;23(Supplement 2):e2021253.

Kikuchi N, Fuku N, Matsumoto R, Matsumoto S, Murakami H, Miyachi M, et al. The Association between MCT1 T1470A polymorphism and power-oriented athletic performance. Int J Sport Med. 2017;38(1):76–80. PubMed

Greenspan G, Geiger D. Model-based inference of haplotype block variation. J Comput Biol. 2004;11(2–3):493–504. PubMed

Abdel-Shafy H, Bortfeldt RH, Tetens J, Brockmann GA. Single nucleotide polymorphism and haplotype effects associated with somatic cell score in German holstein cattle. Genet Sel Evol. 2014;46(1):1–10. PubMed PMC

Cole BS, Hall MA, Urbanowicz RJ, Gilbert-Diamond D, Moore JH. Analysis of Gene-Gene Interactions. Curr Protoc Hum Genet. 2017;95:1.14.1–1.14.10. PubMed

Jorfeldt L, Juhlin-Dannfelt A, Karlsson J. Lactate release in relation to tissue lactate in human skeletal muscle during exercise. J Appl Physiol Respir Env Exerc Physiol. 1978;44(3):350–2. PubMed

Bulgay C, Zorba E, Bayraktar I, Kazan HH, Ulucan K, Ergun MA. Association between mct1 gene polymorphism (rs1049434) with the athletic performance of elite track and field athletes. Spormetre J Phys Educ Sport Sci. 2023;21(1):127–34.

MacIntosh BR, Rishaug P, Svedahl K. Assessment of peak power and short-term work capacity. Eur J Appl Physiol. 2003;88(6):572–9. PubMed

Lopez EID, Smoliga JM, Zavorsky GS. The effect of passive versus active recovery on power output over six repeated Wingate sprints. Res Q Exerc Sport. 2014;85(4):519–26. PubMed

Castañeda-Babarro A. The Wingate Anaerobic Test, a Narrative Review of the protocol variables that affect the results obtained. Appl Sci. 2021;11(16):7417.

Driss T, Vandewalle H. The measurement of maximal (anaerobic) power output on a cycle ergometer: a critical review. Biomed Res Int. 2013;589361. PubMed PMC

MacIejewska-Skrendo A, Cieszczyk P, Chycki J, Sawczuk M, Smółka W. Genetic markers associated with power athlete status. J Hum Kinet. 2019;68(1):17–36. PubMed PMC

Dzitkowska-Zabielska M, Bojarczuk A, Borczyk M, Piechota M, Korostyński M, Adamczyk JG, et al. Transmission distortion of MCT1 rs1049434 among Polish Elite athletes. Genes (Basel). 2022;13(5):870. PubMed PMC

Massidda M, Mendez-Villanueva A, Ginevičienė V, Proia P, Drozdovska SB, Dosenko V, et al. Association of Monocarboxylate Transporter-1 (MCT1) A1470T polymorphism (rs1049434) with Forward Football Player Status. Int J Sport Med. 2018;39(13):1028–34. PubMed

Fedotovskaya ON, Mustafina LJ, Popov DV, Vinogradova OL, Ahmetov II. A common polymorphism of the MCT1 gene and athletic performance. Int J Sport Physiol Perform. 2014;9(1):173–80. PubMed

Łacina P, Butrym A, Mazur G, Bogunia-Kubik K. BSG and MCT1 genetic variants influence survival in multiple myeloma patients. Genes (Basel). 2018;9(5):226. PubMed PMC

González-Haro C, Soria M, Vicente J, Fanlo AJ, Sinués B, Escanero JF. Variants of the solute carrier SLC16A1 gene (MCT1) Associated with metabolic responses during a long-graded test in Road cyclists. J Strength Cond Res. 2015;29(12):3494–505. PubMed

Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 1999;343(Pt 2):281–99. PubMed PMC

Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol. 2004;558(1):5–30. PubMed PMC

Menzies P, Menzies C, McIntyre L, Paterson P, Wilson J, Kemi OJ. Blood lactate clearance during active recovery after an intense running bout depends on the intensity of the active recovery. J Sports Sci. 2010;28(9):975–82. PubMed

Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol - Regul Integr Comp Physiol. 2004;287(3):R502–16. PubMed

Sawczuk M, Banting L, Cięszczyk P, Maciejewska-Karłowska A, Zarębska A, Leońska-Duniec AJ, Jastrzębski Z, et al. MCT1 A1470T: a novel polymorphism for sprint performance? J Sci Med Sport. 2015;18(1):114–8. PubMed

Bethesda (MD). National Library of Medicine (US), National Center for Biotechnology Information [Internet]. 2004 [cited 2024 Feb 10]. dbSNP. Available from: https://www.ncbi.nlm.nih.gov/snp

Guo X, Chen C, Liu B, Wu Y, Chen Y, Zhou X, et al. Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer. Tumor Biol. 2015;36(5):3931–9. PubMed

Fei F, Guo X, Chen Y, Liu X, Tu J, Xing J, et al. Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer. J Cancer Res Clin Oncol. 2015;141(6):1095–102. PubMed PMC

Van Dijkhuizen P, Wulffraat N. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review. Pediatr Rheumatol. 2014;12(51). PubMed PMC

Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A, Hubank M, et al. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenet Genomics. 2010;20(11):665–76. PubMed PMC

Bonen A. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle. Eur J Appl Physiol. 2001;86(1):6–11. PubMed